Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 2 ... vaccinations which were well tolerated and no serious side effects associated with the vaccine candidates were observed. The results demonstrate the potential value of ... AFFiRiS AG announced that the primary endpoints have been met for the Phase I clinical studies of ...
2009 NOV 2 ... According to recent research published in the journal Clinical and Vaccine Immunology, "In the search for better tools to control bovine tuberculosis, the ... For additional information, contact B. Oesch, Prionics AG, Wagistr 27A, CH-8952 Schlieren, Switzerland. The publisher's contact ...
2009 NOV 2 ... A report, 'Transcriptional IL-15-directed in vivo DC targeting DNA vaccine,' is newly published data in Gene Therapy. According to a study from the United States, ... the potency of this novel DNA vaccine strategy was proven using a self/tumor Ag (TRP2) in a clinically relevant B16 melanoma model," wrote S. Tian and colleagues, ...
2009 NOV 9 ... 5-based vectors expressing SIV Gag, Env, and Nef with and without IL-15 and evaluated vaccine immunogenicity," investigators in the United States report. "Vaccination ... investigators in the United States report. "Vaccination increased Ag-specific T cells 20-fold but did not expand the breadth of epitopes recognized or the ...
2009 OCT 19 ... immune responses induced by nanoemulsion-encapsulated MAGE1-HSP70/SEA complex protein vaccine following different administration routes,' are discussed in a new report. According to ... The publisher of the journal Oncology Reports can be contacted at: S. Karger AG, Allschwilerstrasse 10, CH-4009 Basel, Switzerland. Keywords: People's ...
2009 OCT 19 ... to its Supervisory Board. Among his achievements, Dr Plotkin developed a vaccine against the rubella virus. This rubella vaccine continues to be in standard use ...
2009 OCT 12 ... of genes involved in transport, metabolism, stress response, and virulence. Known vaccine candidates, such as BibA and pilus components, were also regulated by pH. We observed ... Biotechnology, Drug Development, Immunization, Medical Device, Metabolism, Novartis AG, Pharmaceutical Business, Pharmaceutical Company, Therapy, Treatment, Vaccination, ...
2009 OCT 19 ... Health, PDS Biotechnology Corporation. This article was prepared by AIDS Vaccine Week editors from staff and other reports. Copyright 2009, AIDS Vaccine Week via ... melanoma, the most aggressive form of skin cancer. The technology is based on Merck AG's proprietary enantiomer exclusively licensed to PDS Biotechnology for use in ...
2009 NOV 1 ... in humans. We have previously reported that RepliVAX WN is a safe and efficacious vaccine in mouse and hamster models of WN disease," researchers in the United States report. ... Keywords: United States, Cambridge, Biotechnology, Flavivirus, Immunization, Novartis AG, Pharmaceutical Business, Pharmaceutical Company, Vaccination, Vaccines, Viral, Virus, ...
2009 NOV 23 ... from lymphocytic choriomeningitis virus (LCMV) and evaluated its potency as an antiviral vaccine. The intramuscular immunization of mice with the peptide-liposome conjugates along with ... challenge via the same route. Complete protection was achieved in mice even when the Ag dose was reduced to as low as 280 ng of liposomal peptide. This form of vaccination with ...
2009 NOV 2 ... and some may induce life-threatening anaphylactic reactions." "An ideal vaccine for desensitization should be highly immunogenic and should alleviate allergic symptoms ... For more information, contact M.F. Bachmann, Cytos Biotechnology AG, Dept. of Immunodrugs, CH-8952 Schlieren, Switzerland. Publisher contact ...
2009 NOV 1 ... vaccines may be considerably different. in addition, memory responses to the same vaccine may be influenced by age, environmental and genetic factors." "emerging ... Keywords: Italy, Siena, Biotechnology, Immunization, Immunology, Novartis AG, Pharmaceutical Business, Pharmaceutical Company, Vaccination, Vaccines, Novartis. ...
2009 OCT 6 ... Schiller and colleagues published their study in Clinical and Vaccine Immunology (Optimization of a Whole-Blood Gamma Interferon Assay for Detection of ... 2009;16(8):1196-1202). For more information, contact B. Oesch, Prionics AG, Wagistr 27A, CH-8952 Schlieren, Switzerland. Publisher contact information ...
2009 NOV 17 ... in humans and the shown protection in animal studies suggest that Spy0416 is a promising vaccine candidate for the prevention of infections by S. pyogenes." Fritzer and ... MCP-1 (monocyte chemoattractant protein 1)," wrote A. Fritzer and colleagues, Intercell AG. The researchers concluded: "The degradation of two human CXC chemokines ...
2009 OCT 19 ... A new study, 'Human HSP70 and modified HPV16 E7 fusion DNA vaccine induces enhanced specific CD8+ T cell responses and anti-tumor effects,' is now ... Publisher contact information for the journal Oncology Reports is: S. Karger AG, Allschwilerstrasse 10, CH-4009 Basel, Switzerland. Keywords: People's ...
